期刊
BIOCHEMICAL PHARMACOLOGY
卷 73, 期 12, 页码 2004-2011出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2007.03.018
关键词
anandamide; arachidonic acid; astrocytes; cannabinoids; cannabinoid receptor subtype-1; endocannabinoids; glutamate transport; MAP kinase; methanadamide
资金
- NCRR NIH HHS [G12RR03045-17] Funding Source: Medline
Cannabinoids have been shown to increase the extracellular levels of glutamate in vivo and in vitro, but no studies have evaluated the possible involvement of glial glutamate reuptake system. The present study investigates whether cannabinoids and endocannabinoid, anandamide have an effect on astroglial excitatory amino acid (EAA) transport. The kinetics of glutamate transport was studied in rat cortical astrocytes, using the radiolabeled, non-metabolized amino acid, D-[H-3] aspartate in the absence or presence of cannabinoid receptor agonists. The results show that in vehicle controls the uptake Of D-aspartate was rapid, sodium-dependent and saturated within the first 5 min, resulting in a K-m 7.365 +/- 1.16 mu mol/L (n = 5) and the maximum velocity (V-max) 1207 +/- 51 nmol/mg protein/min. Addition of the synthetic cannabinoid analog R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolol][1,2,3de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone (WIN 55,212-2; 3 mu mol/L) increased the K-m (26.25 +/- 4.84 mu mol/L) without affecting the V-max (1122 +/- 77 nmol/mg protein/min), suggesting the inhibition was competitive and reversible. Various other cannabinoid agonists also inhibited D-aspartate uptake in a dose-dependent and stereospecific manner. The cannabinoid inhibition of EAA transport was partially blocked by the cannabinoid type-1 (CB1) receptor antagonist N-(piperidin-1-yl-5(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamidehydrochloride (SR141716A; 100 nmol/L). The inhibitory effects of WIN 55,212-2, or its endogenous counterpart anandamide were reversed by 98,059, an inhibitor of mitogen-activated kinase (MAPK) kinase (MEK). These results suggest that cannabinoids and endocannabinoids may constitute a novel class of inhibitors of astroglial glutamate transport system. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据